Altre lingue Oramed Pharmaceuticals Inc. Deutsche Boerse AG

Azioni

OJU1

US68403P2039

Mercato chiuso - Deutsche Boerse AG Altri mercati azionari 11:24:43 23/05/2024			Variaz. 5gg	Var. 1 gen.
2,125 ^EUR	+1,24%		-1,89%	+1,63%

15/05	Compugen nomina David Silberman CFO	MT
09/05	Oramed Pharmaceuticals Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Compugen Names David Silberman CFO	15/05
Oramed Pharmaceuticals : Management Change/Compensation - Form 8-K	13/05
Oramed: Q1 Earnings Snapshot	10/05
Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	06/05
Oramed Pharmaceuticals : 13D-Nadav Kidron	26/03
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	19/03
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	19/03
Oramed Pharmaceuticals : Other Report or Announcement	18/03
Oramed Pharmaceuticals : Other Report or Announcement	18/03
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors	19/01
Oramed Pharmaceuticals : Other Report or Announcement	02/01
Oramed Pharmaceuticals : Other Report or Announcement	24/12
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024	19/12
Oramed Pharmaceuticals : Form 8-K - Director Appointment- Dr. Daniel Aghion, effective as of January 1, 2024.	19/12
Oramed: Q3 Earnings Snapshot	10/11
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Oramed Pharmaceuticals Inc.(TASE:ORMP) dropped from TA-125 Index	03/11
Scilex Consummates Purchase of Securities Owned by Sorrento Therapeutics	21/09/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Oramed Pharmaceuticals Inc. Deutsche Boerse AG

Azioni

OJU1

US68403P2039

Altre lingue

Filtri